Automatic Data Processing Inc vs ARK Genomic Revolution ETF — how do they compare? Automatic Data Processing Inc trades at $268.24 (market cap $107.69B), while ARK Genomic Revolution ETF trades at $44.49. The key difference: Automatic Data Processing Inc pays a 2.51% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Automatic Data Processing Inc nearer its low. Which is the better fit depends on your goals.
| ADP | ARKG | |
|---|---|---|
Market Cap | $107.69B | — |
Sector | Industrials | Sector/Thematic |
52-Week High | $309.03 | $44.55 |
52-Week Low | $188.79 | $24.02 |
Enterprise Value | $108.73B | — |
Dividend Yield | 2.51% | — |
Signals from Pluang's Aura AI — not financial advice
ADP trades at $273.68, up 0.87% today, near its consensus price target of $280.50. The stock shows bullish technical signals with strong moving averages and support at $270. Recent quarterly earnings consistently beat estimates, with Q2 2026 EPS of $2.64 surpassing the $2.59 forecast. Revenue growth is steady, reaching $20.56 billion in 2025, with a net income margin of 20.11% and robust ROE of 72.24%.
Outlook remains positive given earnings momentum and dividend stability, but high valuation multiples (P/E 24.78, P/S 4.98) pose risks if growth slows. Analyst sentiment is mixed with 63.89% hold ratings, reflecting caution amid elevated prices. Key risks include labor market sensitivity and competitive pressures in payroll processing.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Read more on ADP →ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →